BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6262168)

  • 1. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
    Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
    Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
    Pun KK; Young RT; Wang C; Tam CF; Ho PW
    J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
    Nelson RL; Service FJ; Go VL
    Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose turnover in insulinoma--a case report.
    Hanna AK; Vranic M; Zinman B
    Diabetes Res Clin Pract; 1987; 3(2):111-4. PubMed ID: 3032548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.
    Del Prato S; Riccio A; Vigili de Kreutzenberg S; Dorella M; Avogaro A; Marescotti MC; Tiengo A
    Metabolism; 1993 Jan; 42(1):24-9. PubMed ID: 8446044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative prolonged fast: functional and morphological properties.
    Wiesli P; Schmid C; Perren A; Pfammatter T; Spinas GA; Keller U
    J Endocrinol Invest; 2004 Oct; 27(9):832-8. PubMed ID: 15648547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
    Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose counterregulatory hormones in the 72-hour fast.
    Vella A; Service FJ; O'Brien PC
    Endocr Pract; 2003; 9(2):115-8. PubMed ID: 12917072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
    Connolly CC; Adkins-Marshall BA; Neal DW; Pugh W; Jaspan JB; Cherrington AD
    Diabetes; 1992 Oct; 41(10):1308-19. PubMed ID: 1397705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiles in patients with insulinoma.
    Hale PJ; Nattrass M
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):29-38. PubMed ID: 2550166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are elevated pancreatic polypeptide levels in patients with insulinoma secondary to hypoglycaemia?
    Nelson RL; Service FJ; Ilstrup DM; Go VL
    Lancet; 1980 Sep; 2(8196):659-61. PubMed ID: 6106782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of suppression of insulin secretion by hyperinsulinemia in a patient with an insulinoma.
    Cohen P; Barzilai N; Bar-Ilan R; Yassin K; Karnieli E
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1411-3. PubMed ID: 3023422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Diagnosis of insulinoma.
    Lancet; 1974 Aug; 2(7877):385-6. PubMed ID: 4136659
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism.
    Gin H; Brottier E; Dupuy B; Guillaume D; Ponzo J; Aubertin J
    Arch Intern Med; 1987 May; 147(5):985-7. PubMed ID: 3034180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.